Connection

SILVANA DE CASTRO FARIA to Janus Kinase 2

This is a "connection" page, showing publications SILVANA DE CASTRO FARIA has written about Janus Kinase 2.
Connection Strength

0.080
  1. Phase I study of a novel oral Janus kinase 2 inhibitor, SB1518, in patients with relapsed lymphoma: evidence of clinical and biologic activity in multiple lymphoma subtypes. J Clin Oncol. 2012 Nov 20; 30(33):4161-7.
    View in: PubMed
    Score: 0.080
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.